ARVL - Spotify Technology Pinterest among premarket losers' pack
Protalix BioTherapeutics (PLX) -43% on FDA rejection of experimental therapy for Fabry disease.Benitec Biopharma (BNTC) -22% after secures $13M capital via equity offering.Urban Tea (MYT) -13% on 1H earnings releasePinterest (PINS) -12% on Q1 earnings release.Brooklyn ImmunoTherapeutics (BTX) -11%.Nxt-ID (NXTD) -8%.Enphase Energy (ENPH) -8% on Q1 earnings release.R. R. Donnelley & Sons (RRD) -8% on Q1 earnings release.Discovery (DISCA) -7% on Q1 earnings release.Spotify Technology (SPOT) -7% on Q1 earnings release.Discovery (DISCK) -7% on Q1 earnings release.Veoneer (VNE) -6% on Q1 earnings release.DermTech (DMTK) -6%.AzurRx BioPharma (AZRX) -6%.Uxin (UXIN) -5% on FQ3 earnings release.Arrival (ARVL) -5%.
For further details see:
Spotify Technology, Pinterest among premarket losers' pack